• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pavmed Inc (NQ: PAVM )

    1.140 +0.050 (+4.59%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pavmed Inc

    < Previous 1 2 3 4 5 6 7 Next >
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers 
    Via Benzinga
    PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
    From PAVmed Inc.
    Via Business Wire
    Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
    From Lucid Diagnostics Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
    Via Benzinga
    Earnings Scheduled For May 12, 2022
    Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
    Via Benzinga
    Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
    From Lucid Diagnostics Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    61 Biggest Movers From Yesterday
    Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with... 
    Via Benzinga
    PAVmed to Hold a Business Update Conference Call on May 12, 2022
    From PAVmed Inc.
    Via Business Wire
    Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
    From Lucid Diagnostics Inc.
    Via Business Wire
    PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
    From PAVmed Inc.
    Via Business Wire
    Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
    From Lucid Diagnostics Inc.
    Via Business Wire
    The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
    From Lucid Diagnostics Inc.
    Via Business Wire
    Earnings Preview: PAVmed
    PAVmed (NASDAQ:PAVM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that PAVmed will report an... 
    Via Benzinga
    PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
    From Lucid Diagnostics Inc.
    Via Business Wire
    Earnings Scheduled For March 29, 2022
    Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million. 
    Via Benzinga
    PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
    From Lucid Diagnostics Inc.
    Via Business Wire
    The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
    Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. 
    Via Benzinga
    PAVmed Highlights First-In-Human Implantations of its PortIO Infusion System
    PAVmed Inc (NASDAQ: PAVM) announced the successful implantation of its PortIO Intraosseous Infusion System in three patients as part of a first-in-human (FIH)... 
    Via Benzinga
    PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
    From PAVmed Inc.
    Via Business Wire
    64 Biggest Movers From Yesterday
    Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
    Via Benzinga
    PAVmed Appoints Shaun O’Neil as Chief Operating Officer
    From PAVmed Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
    Via Benzinga
    Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
    From PAVmed Inc.
    Via Business Wire
    Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
    From Lucid Diagnostics Inc.
    Via Business Wire
    PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
    From PAVmed Inc. and Lucid Diagnostics Inc.
    Via Business Wire
    Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
    From Lucid Diagnostics Inc.
    Via Business Wire
    50 Biggest Movers From Yesterday
    Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.